PS

Paresh Soni

AL Amarin Pharmaceuticals Ireland Limited: 18 patents #1 of 9Top 15%
📍 Mystic, CT: #1 of 31 inventorsTop 4%
🗺 Connecticut: #14 of 4,045 inventorsTop 1%
Overall (2021): #2,349 of 548,734Top 1%
18
Patents 2021

Issued Patents 2021

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
11185525 Methods of reducing apolipoprotein C-III Mehar Manku, Ian Osterloh, Pierre Wicker, Rene Braeckman, Joseph S. Zakrzewski 2021-11-30
11179362 Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy Ian Osterloh, Pierre Wicker, Rene Braeckman, Mehar Manku 2021-11-23
11154526 Methods of treating mixed dyslipidemia Ian Osterloh, Pierre Wicker, Rene Braeckman, Mehar Manku 2021-10-26
11147787 Stable pharmaceutical composition and methods of using same Mehar Manku, Ian Osterloh, Pierre Wicker, Rene Braeckman 2021-10-19
11141399 Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis Mehar Manku, Pierre Wicker, Rene Braeckman, Joseph S. Zakrzewski 2021-10-12
11116742 Methods of reducing the risk of cardiovascular events in a subject 2021-09-14
11116743 Methods of reducing the risk of cardiovascular events in a subject 2021-09-14
11103477 Stable pharmaceutical composition and methods of using same Mehar Manku, Ian Osterloh, Pierre Wicker, Rene Braeckman 2021-08-31
11052063 Methods of reducing RLP-C Ian Osterloh, Pierre Wicker, Rene Braeckman, Mehar Manku 2021-07-06
11033523 Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same Mehar Manku, Ian Osterloh, Pierre Wicker, Rene Braeckman 2021-06-15
11000499 Methods of reducing the risk of cardiovascular events in a subject 2021-05-11
10987331 Methods of treating mixed dyslipidemia Ian Osterloh, Pierre Wicker, Rene Braeckman, Mehar Manku 2021-04-27
10973797 Methods of reducing apolipoprotein c-III Mehar Manku, Ian Osterloh, Pierre Wicker, Rene Braeckman, Joseph S. Zakrzewski 2021-04-13
10973796 Compositions and methods for lowering levels of high-sensitivity C-reactive protein (hs-CRP) in a subject Mehar Manku, Ian Osterloh, Pierre Wicker, Rene Braeckman 2021-04-13
10966968 Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof Rene Braeckman, William Stirtan 2021-04-06
10940131 Methods of treating mixed dyslipidemia Ian Osterloh, Pierre Wicker, Rene Braeckman, Mehar Manku 2021-03-09
10894028 Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease 2021-01-19
10881632 Stable pharmaceutical composition and methods of using same Mehar Manku, Ian Osterloh, Pierre Wicker, Rene Braeckman 2021-01-05